Nurse Practitioner, Acute Care · Ada, OK
NPI
1659034221
Since 2021
Specialty
Nurse Practitioner, Acute Care
Code 363LA2100X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1921 Stonecipher Blvd
Ada, OK, 74820
Phone (580) 436-3980
Groups this clinician bills Medicare through
Medicare paid, 2024
$13K
224 services
Medicare patients, 2024
139
Average age 70
Drug cost, 2024
$3.7M
2,405 prescriptions
Company payments, 2025
$246
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ramona J Baker was code 99214 (office e&m - established), 184 times for 128 patients. In total Ramona J Baker billed 224 services in 8 codes, and Medicare paid $13K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 184 | 128 | $58.51 | $11K |
| 99215 Office E&M - Established | Facility | 19 | 17 | $71.76 | $1,363 |
By year: 2022 $31K for 487 services; 2023 $13K for 171 services; 2024 $13K for 224 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ramona J Baker prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 530 prescriptions and refills. In total Ramona J Baker wrote 2,405 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 530 | 530 | 82 | $77K |
| Diclofenac Sodium Generic | 286 | 286 | 71 | $12K |
| Duloxetine Hcl Generic | 177 | 177 | 29 | $32K |
| Leflunomide Generic | 104 | 104 | 18 | $20K |
| Methotrexate Methotrexate Sodium | 95 | 95 | 18 | $11K |
| Lidocaine Generic | 94 | 94 | 23 | $13K |
| Alendronate Sodium Generic | 77 | 77 | 12 | $5,115 |
| Prednisone Generic | 76 | 76 | 24 | $588 |
| Enbrel Sureclick Etanercept | 69 | 69 | Under 11 | $537K |
| Celecoxib Generic | 69 | 69 | 15 | $14K |
| Gabapentin Generic | 65 | 65 | 13 | $3,454 |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 61 | 61 | Under 11 | $562K |
| Rasuvo Methotrexate/Pf | 56 | 56 | Under 11 | $33K |
| Xeljanz Xr Tofacitinib Citrate | 52 | 52 | Under 11 | $311K |
| Remicade Infliximab | 45 | 57 | Under 11 | $380K |
Brand drugs: 674 claims; generic drugs: 1,731 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ramona J Baker $246 ($246 in general payments such as food, travel and fees) from 2 companies. The largest payer was Xeris Pharmaceuticals, Inc. with $124.
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 1 | $124 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $122 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.